Investigation area: Oncology

The Oncology area is made up of 14 research groups, around which more than 200 researchers are grouped. This volume of groups and researchers indicates the importance and intensity that research on the problem of cancer implies for ibs.GRANADA itself. The main concern of this Area lies in the need to understand this health problem from very diverse perspectives, since the opportunities to improve its understanding, as well as the strategies to control it, arise from very broad and diverse spaces of knowledge. It is precisely the interaction between the different groups in the area, with their different approaches to the same problem, which will allow progress in the aforementioned aspects, becoming one of our main strengths.

The objectives of the Oncology area are:

a) Promote a transversal and open vision of cancer research approaches, in which basic, clinical and epidemiological research of the highest level is present.

b) Encourage and stimulate cooperation between research groups, which crystallize in projects and collaborative work of a translational nature.

c) Strengthen its lines of research, among which the following should be specifically highlighted:

• The evaluation of results, the quality of healthcare, and integrative oncology
• Environmental contamination and development of neoplasms.
• Research on specific molecular and genetic analysis techniques on predictive factors, biomarkers and immunotherapy in the context of personalized medicine.
• Development of new therapeutic strategies: new antitumor agents, gene therapy strategies and new techniques for the use of radiation and surgical techniques.

Line: Epidemiology and prevention of cancer. Quality of life and health care in cancer patients.

Line B: Identification of factors involved in the diagnosis and prognosis of cancer. Clinical and molecular diagnosis and the immune response.

Line C: Therapies applied to oncology. Design of new drugs and mechanisms of resistance and prediction of response to chemotherapy and radiotherapy.